Troy Asset Management Ltd Boosts Stock Position in Agilent Technologies, Inc. $A

Troy Asset Management Ltd increased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 0.3% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 2,404,161 shares of the medical research company’s stock after purchasing an additional 6,341 shares during the period. Agilent Technologies makes up approximately 7.8% of Troy Asset Management Ltd’s holdings, making the stock its 4th largest position. Troy Asset Management Ltd’s holdings in Agilent Technologies were worth $308,574,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Capital A Wealth Management LLC raised its stake in Agilent Technologies by 10,600.0% during the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 212 shares during the last quarter. Davis Capital Management acquired a new position in shares of Agilent Technologies during the third quarter valued at about $28,000. Physician Wealth Advisors Inc. lifted its stake in shares of Agilent Technologies by 490.0% in the third quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after buying an additional 196 shares during the period. State of Wyoming bought a new stake in shares of Agilent Technologies in the second quarter valued at about $35,000. Finally, SJS Investment Consulting Inc. grew its position in Agilent Technologies by 2,836.4% during the third quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock worth $41,000 after buying an additional 312 shares in the last quarter. Institutional investors and hedge funds own 87.41% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on A. Evercore upgraded shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and lifted their price target for the stock from $155.00 to $160.00 in a research note on Monday, January 5th. JPMorgan Chase & Co. upped their target price on shares of Agilent Technologies from $165.00 to $180.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Agilent Technologies in a research note on Monday, December 29th. Wells Fargo & Company raised their price objective on shares of Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Finally, Citigroup boosted their target price on Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a report on Tuesday, November 25th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $164.50.

Insider Buying and Selling

In other Agilent Technologies news, VP Rodney Gonsalves sold 3,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the transaction, the vice president owned 31,846 shares of the company’s stock, valued at $4,935,811.54. The trade was a 8.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Padraig Mcdonnell sold 911 shares of the business’s stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total value of $130,491.64. Following the transaction, the chief executive officer directly owned 32,058 shares in the company, valued at $4,591,987.92. The trade was a 2.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.26% of the stock is owned by company insiders.

Agilent Technologies Price Performance

Shares of A stock opened at $125.80 on Friday. The firm’s 50 day moving average price is $137.84 and its two-hundred day moving average price is $135.41. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $160.27. The stock has a market cap of $35.58 billion, a PE ratio of 27.53, a PEG ratio of 3.65 and a beta of 1.30.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, beating analysts’ consensus estimates of $1.58 by $0.01. The business had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The firm’s quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.46 EPS. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st will be given a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.02 annualized dividend and a yield of 0.8%. Agilent Technologies’s dividend payout ratio is 22.32%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.